Search

everythinglearnresearchcommunity

for

Search:↓

EGFR inhibitors can cause skin issues, but managing them is important for treatment success.

Decreasing MIG6 can increase the movement and invasiveness of MEK-inhibited mutant NRAS melanoma, particularly when stimulated by EGF.

Netherton syndrome is a genetic skin disorder causing severe skin issues and requires careful treatment to protect the skin barrier.

Thujae occidentalis semen extract may help treat male pattern baldness by blocking a hair loss-related enzyme and reducing hair loss in mice.

A bull with a gene mutation was asymptomatic, synthetic retinoids cause hair loss, and new therapeutic targets were identified for skin diseases.

A man developed a rash similar to pityriasis rubra pilaris after starting sorafenib for cancer, possibly due to the drug's effect on skin cells.

Tofacitinib may help hair regrowth in familial alopecia areata with immune issues, but more research is needed.

The new compound was more effective than finasteride in reducing markers of hair loss and prostate issues in cell tests.

Ishige sinicola, a type of seaweed, may help hair grow by blocking a hair loss-related enzyme and boosting important cell growth.

Lipids from Schizochytrium sp. help prevent hair loss by protecting hair cells from damage and promoting hair growth.

Ritlecitinib effectively reduces hair loss in JAK inhibitor-naïve alopecia areata patients.

ZD1839 can cause skin issues like acne and hair changes.

Sorafenib can cause facial acne-like eruptions, which improve after reducing the dose or stopping the drug.

Scientists found gene mutations that affect hair loss, skin stem cells, and skin disorders, and identified drugs that may help treat blood vessel and skin conditions.

Baricitinib effectively improved both atopic dermatitis and alopecia areata symptoms in a patient.

The compound 4c effectively inhibits the enzyme linked to hair loss.

Cancer treatments can cause hair loss, but it is often reversible and can be managed with scalp cooling and support.

Suppressing ODC activity reduces tumor growth in hair follicles.

Blocking certain immune signals can reduce skin damage from radiation therapy.

Brepocitinib improves cicatricial alopecia and reduces key immune markers.

Cepharanthine, a Japanese hair loss drug, shows promise as a COVID-19 treatment but needs more testing.

Sebaceous glands in the skin play a key role in absorbing the antiandrogen drug RU 58841, especially when it's encapsulated in liposomes.

Hair color loss can indicate the effectiveness of a drug targeting the KIT protein in mice and humans.

Some patients with mycosis fungoides or Sézary syndrome experience hair loss, which may be similar to alopecia areata or linked to skin lesions, possibly due to abnormal T cells, and bexarotene can help treat it.

Tyrosine Kinase Inhibitors are effective against cancer but can cause skin, digestive, and blood side effects, including hair loss.

Hes1 protein is important for hair growth and regeneration, and could be a potential treatment for hair loss.

The topical inhibitor CUR61414 was not effective in treating basal cell carcinoma in human trials.

JAK inhibitors can help regrow hair in alopecia areata but have potential long-term risks and require careful monitoring.

Excess sebum reduces the effectiveness of nanosystems for treating hair follicle conditions.

Blocking DGAT1 reduces oil gland size in mice and dogs, but only mice experience hair loss.